查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1720777

2025年全球糖尿病诊断市场报告

Diabetes Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年糖尿病诊断市场规模将强劲成长。到 2029 年，这一数字将成长至 367.2 亿美元，复合年增长率为 7.6%。预测期内的成长归因于胰岛素帮浦的普及、糖尿病技术的进步、不健康生活习惯的盛行、1 型和 2 型糖尿病患者数量的快速增加以及医疗保健基础设施的扩展。主要趋势包括生物感测器技术的进步、诊断技术的创新、个人化医疗和标靶治疗的兴起以及先进体外诊断技术的发展。

预计未来几年肥胖率的上升将推动糖尿病诊断市场的成长。肥胖的特征是体内脂肪过度堆积，会增加罹患多种健康疾病的风险，包括心臟病和糖尿病。肥胖发病率的上升与久坐不动的生活方式、加工食品和高热量食品的消费量增加、遗传倾向和体力活动减少等因素有关。糖尿病诊断在肥胖管理中发挥关键作用，可以早期发现胰岛素阻抗和葡萄糖代谢问题，从而及时干预，防止体重增加和相关的健康併发症。例如，美国政府机构疾病管制与预防中心于2023年9月报告称，2022年成人肥胖率达到或超过35%的州有22个，高于2021年的19个州。肥胖率的上升正在促进糖尿病诊断市场的扩张。

糖尿病诊断市场中的公司正在扩大其产品组合，并专注于开发妊娠糖尿病诊断工具等创新产品，以满足对妊娠糖尿病早期检测和管理日益增长的需求。这些工具包括用于检测和监测孕妇妊娠糖尿病的医疗设备和测试，通常涉及血糖测试，如口服葡萄糖耐受测试 (OGTT)，以评估身体在怀孕期间如何处理糖分。例如，2024 年 8 月，奥地利生物技术公司 DirectSens GmbH 推出了 XpressGT RUO套件，这是一种用于检测与胰岛素抗性相关的疾病（例如妊娠期糖尿病、子宫内膜异位症和肝病）的尖端生物感测器工具。该套件透过测量静脉血液中的 2-羟基丁酸 (2-HB) 水平来快速提供结果，并与标准临床分析仪相容。这项创新可以促进早期诊断并改善全球数百万名患者的健康状况。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 - 市场 - 宏观经济情境 宏观经济情境包括利率、通膨、地缘政治以及感染疾病和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球糖尿病诊断PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球糖尿病诊断市场：成长率分析
  • 全球糖尿病诊断市场表现：规模与成长，2019-2024
  • 全球糖尿病诊断市场预测：规模与成长，2024-2029 年，2034 年
  • 全球糖尿病诊断总目标市场（TAM）

第六章市场区隔

  • 全球糖尿病诊断市场：依产品类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 血糖测量装置
  • 连续血糖监测装置
  • 《采血针》
  • 测试条
  • 其他产品类型
  • 全球糖尿病诊断市场（依糖尿病类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 糖尿病
  • 2型糖尿病
  • 妊娠糖尿病
  • 全球糖尿病诊断市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断中心
  • 居家照护环境
  • 其他最终用户
  • 全球糖尿病诊断市场细分（按血糖仪类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 常规血糖测量装置
  • 智慧型血糖仪
  • 蓝牙血糖监测仪
  • 全球糖尿病诊断市场连续血糖监测设备细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 穿戴式CGM系统
  • 植入式CGM系统
  • Flash血糖监测仪
  • 全球糖尿病诊断市场依采血针类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 免稍后采血针
  • 多用途采血针
  • 全球糖尿病诊断市场，按试纸类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 标准试纸
  • 智慧试纸
  • 全球糖尿病诊断市场，按其他产品类型细分，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 糖化血红素 A1c检测套组
  • 尿糖试纸
  • 血酮仪

第七章 区域和国家分析

  • 全球糖尿病诊断市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球糖尿病诊断市场：依国家、表现及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 糖尿病诊断市场：竞争格局
  • 糖尿病诊断市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Novartis AG
  • 3M Company
  • Medtronic plc
  • Regeneron Pharmaceuticals Inc.
  • Carl Zeiss Meditec AG
  • Bausch & Lomb Incorporated
  • DexCom Inc
  • Santen Pharmaceutical Co. Ltd.
  • Topcon Corporation
  • Tandem Diabetes Care Inc
  • Ypsomed AG
  • LifeScan Inc
  • Nova Biomedical Corporation
  • Ascensia Diabetes Care Holdings AG
  • ARKRAY Inc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年糖尿病诊断市场：提供新机会的国家
  • 2029年糖尿病诊断市场：细分市场将带来新机会
  • 2029年糖尿病诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r34033

Diabetes diagnostics encompasses the methods and tests used to detect and monitor diabetes by measuring blood glucose levels and other relevant biomarkers. These assessments help identify abnormal glucose metabolism, assess diabetes risk or presence, and support early detection, disease management, and treatment planning.

The primary product types in diabetes diagnostics include blood glucose meters, continuous glucose monitoring devices, lancets, test strips, and others. Blood glucose meters are portable medical devices that measure blood sugar levels by analyzing a small drop of blood, usually from a fingertip, placed on a test strip. These devices are used for Type I diabetes, Type II diabetes, and gestational diabetes across various settings, including hospitals, diagnostic centers, home care, and others.

The diabetes diagnostics market research report is one of a series of new reports from The Business Research Company that provides diabetes diagnostics market statistics, including the diabetes diagnostics industry global market size, regional shares, competitors with the diabetes diagnostics market share, detailed diabetes diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the diabetes diagnostics industry. This diabetes diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diabetes diagnostics market size has grown strongly in recent years. It will grow from $25.39 billion in 2024 to $27.39 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth during the historic period can be credited to the rising prevalence of diabetes, an expanding geriatric population, increasing sedentary lifestyles, greater adoption of minimally invasive diagnostics, and the growing prevalence of obesity.

The diabetes diagnostics market size is expected to see strong growth in the next few years. It will grow to $36.72 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be credited to the rising adoption of insulin pumps, advancements in diabetes technology, increasing prevalence of unhealthy lifestyles, a surge in Type 1 and Type 2 diabetes cases, and the expansion of healthcare infrastructure. Key trends include advancements in biosensor technology, innovations in diagnostic technologies, the rise of personalized medicine and targeted therapies, and the development of advanced in vitro diagnostic products.

The increasing prevalence of obesity is expected to drive the growth of the diabetes diagnostics market in the coming years. Obesity is characterized by excessive accumulation of body fat, which raises the risk of several health conditions, including heart disease and diabetes. The growing incidence of obesity is linked to factors such as sedentary lifestyles, higher consumption of processed and high-calorie foods, genetic predisposition, and reduced physical activity. Diabetes diagnostics play a crucial role in obesity management by identifying insulin resistance and glucose metabolism issues early, allowing for timely interventions to prevent weight gain and associated health complications. For example, in September 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, 22 states had an adult obesity rate of 35% or higher, up from 19 states in 2021. This increasing obesity rate is contributing to the expansion of the diabetes diagnostics market.

Companies operating in the diabetes diagnostics market are focusing on developing innovative products, such as gestational diabetes diagnostic tools, to broaden their product offerings and meet the rising demand for early detection and management of diabetes during pregnancy. These tools include medical devices and tests designed to detect and monitor gestational diabetes in pregnant women, often involving blood glucose testing, such as the oral glucose tolerance test (OGTT), to evaluate how the body processes sugar during pregnancy. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced the XpressGT RUO kit, a cutting-edge biosensor tool for detecting insulin resistance-related conditions, including gestational diabetes, endometriosis, and liver disease. This kit provides rapid results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with standard clinical analyzers. This innovation is designed to facilitate early diagnostics, potentially improving health outcomes for millions of patients worldwide.

In September 2023, Abbott Laboratories Ltd., a US-based medical device company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition aims to strengthen Abbott's position in diabetes care, expand its FreeStyle Libre portfolio, and advance its efforts in developing connected solutions for more personalized and precise diabetes management. Bigfoot Biomedical Inc. is a US-based medical technology company focused on creating innovative solutions for insulin management.

Major players in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, and DarioHealth Corp.

North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in diabetes diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diabetes diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diabetes diagnostics market consists of revenues earned by entities by providing services such as insulin sensitivity and resistance testing, neuropathy testing services, retinopathy screening services, and diabetes risk assessment services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes diagnostics market also includes sales of glucose monitoring devices, HbA1c testing kits, and insulin pumps. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diabetes Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diabetes diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diabetes diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diabetes diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Blood Glucose Meters; Continuous Glucose Monitoring Devices; Lancets; Test Strips; Other Product Types
  • 2) By Diabetes Type: Diabetes I; Diabetes II; Gestational Diabetes
  • 3) By End-User: Hospitals; Diagnostic Centers; Homecare Settings; Other End-Users
  • Subsegments:
  • 1) By Blood Glucose Meters: Traditional Blood Glucose Meters; Smart Blood Glucose Meters; Bluetooth-enabled Blood Glucose Meters
  • 2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems; Implantable CGM Systems; Flash Glucose Monitoring Devices
  • 3) By Lancets: Single-use Lancets; Multi-use Lancets
  • 4) By Test Strips: Standard Test Strips; Smart Test Strips
  • 5) By Other Product Types: Hemoglobin A1c Testing Kits; Urine Glucose Test Strips; Blood Ketone Meters
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; Bayer AG; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diabetes Diagnostics Market Characteristics

3. Diabetes Diagnostics Market Trends And Strategies

4. Diabetes Diagnostics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Diabetes Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Diabetes Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Diabetes Diagnostics Market Growth Rate Analysis
  • 5.4. Global Diabetes Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Diabetes Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Diabetes Diagnostics Total Addressable Market (TAM)

6. Diabetes Diagnostics Market Segmentation

  • 6.1. Global Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Meters
  • Continuous Glucose Monitoring Devices
  • Lancets
  • Test Strips
  • Other Product Types
  • 6.2. Global Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diabetes I
  • Diabetes II
  • Gestational Diabetes
  • 6.3. Global Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Homecare Settings
  • Other End-Users
  • 6.4. Global Diabetes Diagnostics Market, Sub-Segmentation Of Blood Glucose Meters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Blood Glucose Meters
  • Smart Blood Glucose Meters
  • Bluetooth-enabled Blood Glucose Meters
  • 6.5. Global Diabetes Diagnostics Market, Sub-Segmentation Of Continuous Glucose Monitoring Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wearable CGM Systems
  • Implantable CGM Systems
  • Flash Glucose Monitoring Devices
  • 6.6. Global Diabetes Diagnostics Market, Sub-Segmentation Of Lancets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-use Lancets
  • Multi-use Lancets
  • 6.7. Global Diabetes Diagnostics Market, Sub-Segmentation Of Test Strips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Standard Test Strips
  • Smart Test Strips
  • 6.8. Global Diabetes Diagnostics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemoglobin A1c Testing Kits
  • Urine Glucose Test Strips
  • Blood Ketone Meters

7. Diabetes Diagnostics Market Regional And Country Analysis

  • 7.1. Global Diabetes Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Diabetes Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diabetes Diagnostics Market

  • 8.1. Asia-Pacific Diabetes Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diabetes Diagnostics Market

  • 9.1. China Diabetes Diagnostics Market Overview
  • 9.2. China Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diabetes Diagnostics Market

  • 10.1. India Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diabetes Diagnostics Market

  • 11.1. Japan Diabetes Diagnostics Market Overview
  • 11.2. Japan Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diabetes Diagnostics Market

  • 12.1. Australia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diabetes Diagnostics Market

  • 13.1. Indonesia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diabetes Diagnostics Market

  • 14.1. South Korea Diabetes Diagnostics Market Overview
  • 14.2. South Korea Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diabetes Diagnostics Market

  • 15.1. Western Europe Diabetes Diagnostics Market Overview
  • 15.2. Western Europe Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diabetes Diagnostics Market

  • 16.1. UK Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diabetes Diagnostics Market

  • 17.1. Germany Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diabetes Diagnostics Market

  • 18.1. France Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diabetes Diagnostics Market

  • 19.1. Italy Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diabetes Diagnostics Market

  • 20.1. Spain Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diabetes Diagnostics Market

  • 21.1. Eastern Europe Diabetes Diagnostics Market Overview
  • 21.2. Eastern Europe Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diabetes Diagnostics Market

  • 22.1. Russia Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diabetes Diagnostics Market

  • 23.1. North America Diabetes Diagnostics Market Overview
  • 23.2. North America Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diabetes Diagnostics Market

  • 24.1. USA Diabetes Diagnostics Market Overview
  • 24.2. USA Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diabetes Diagnostics Market

  • 25.1. Canada Diabetes Diagnostics Market Overview
  • 25.2. Canada Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diabetes Diagnostics Market

  • 26.1. South America Diabetes Diagnostics Market Overview
  • 26.2. South America Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diabetes Diagnostics Market

  • 27.1. Brazil Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diabetes Diagnostics Market

  • 28.1. Middle East Diabetes Diagnostics Market Overview
  • 28.2. Middle East Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diabetes Diagnostics Market

  • 29.1. Africa Diabetes Diagnostics Market Overview
  • 29.2. Africa Diabetes Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Diabetes Diagnostics Market, Segmentation By Diabetes Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Diabetes Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diabetes Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Diabetes Diagnostics Market Competitive Landscape
  • 30.2. Diabetes Diagnostics Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Diabetes Diagnostics Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. 3M Company
  • 31.3. Medtronic plc
  • 31.4. Regeneron Pharmaceuticals Inc.
  • 31.5. Carl Zeiss Meditec AG
  • 31.6. Bausch & Lomb Incorporated
  • 31.7. DexCom Inc
  • 31.8. Santen Pharmaceutical Co. Ltd.
  • 31.9. Topcon Corporation
  • 31.10. Tandem Diabetes Care Inc
  • 31.11. Ypsomed AG
  • 31.12. LifeScan Inc
  • 31.13. Nova Biomedical Corporation
  • 31.14. Ascensia Diabetes Care Holdings AG
  • 31.15. ARKRAY Inc

32. Global Diabetes Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diabetes Diagnostics Market

34. Recent Developments In The Diabetes Diagnostics Market

35. Diabetes Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Diabetes Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Diabetes Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Diabetes Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer